Research programme: cyclin-dependent kinase inhibitors - Banyu
Alternative Names: cyclin-dependent kinase inhibitors research programme - BanyuLatest Information Update: 12 Feb 2008
At a glance
- Originator Banyu
- Class
- Mechanism of Action Cyclin-dependent kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 Sep 2004 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 19 Sep 2001 Preclinical development for Cancer in Japan (Unknown route)